Menu
Back to User profile » Dr Xiang-Yu Meng
Papers published by Dr Xiang-Yu Meng:
High CD3D/CD4 ratio predicts better survival in muscle-invasive bladder cancer
Shi MJ, Meng XY, Wu QJ, Zhou XH
Cancer Management and Research 2019, 11:2987-2995
Published Date: 12 April 2019
The association between metabolic syndrome and bladder cancer susceptibility and prognosis: an updated comprehensive evidence synthesis of 95 observational studies involving 97,795,299 subjects
Peng XF, Meng XY, Wei C, Xing ZH, Huang JB, Fang ZF, Hu XQ, Liu QM, Zhu ZW, Zhou SH
Cancer Management and Research 2018, 10:6263-6274
Published Date: 26 November 2018
Vaginal cuff length during radical hysterectomy is a prognostic factor for stage IB-IIA cervical cancer: a retrospective study
Zuo N, Hu H, Thapa N, Li Z, Jiang D, Meng X, Yang J, Chen X, Cai H
Cancer Management and Research 2018, 10:5927-5935
Published Date: 19 November 2018
Treatment options for refractory/relapsed multiple myeloma: an updated evidence synthesis by network meta-analysis
Luo XW, Du XQ, Li JL, Liu XP, Meng XY
Cancer Management and Research 2018, 10:2817-2823
Published Date: 21 August 2018
Induction regimens for transplant-eligible patients with newly diagnosed multiple myeloma: a network meta-analysis of randomized controlled trials
Zeng ZH, Chen JF, Li YX, Zhang R, Xiao L, Meng XY
Cancer Management and Research 2017, 9:287-298
Published Date: 10 July 2017
Concurrent cisplatin-based chemoradiotherapy versus exclusive radiotherapy in high-risk cervical cancer: a meta-analysis
Meng XY, Liao Y, Liu XP, Li S, Shi MJ, Zeng XT
OncoTargets and Therapy 2016, 9:1875-1888
Published Date: 31 March 2016